| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, July 2007, p. 2631-2635, Vol. 51, No. 7
0066-4804/07/$08.00+0 doi:10.1128/AAC.01492-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Abigail N. Layton,1,
Terry R. Field,1
Alison J. Bowen,1
Hans Wolf-Watz,2
Mikael Elofsson,3
Mark P. Stevens,1 and
Edouard E. Galyov1*
Division of Microbiology, Institute for Animal Health, Compton, Berkshire RG20 7NN, United Kingdom,1 Department of Molecular Biology,2 Department of Chemistry, Umeå University, SE-90187 Umeå, Sweden3
Received 28 November 2006/ Returned for modification 2 February 2007/ Accepted 3 May 2007
Type III secretion systems (T3SS) are conserved in many pathogenic gram-negative bacteria. Small molecules that specifically target T3SS in Yersinia and Chlamydia spp. have recently been identified. Here we show that two such compounds inhibit Salmonella T3SS-1, preventing secretion of T3SS-1 effectors, invasion of cultured epithelial cells, and enteritis in vivo.
Published ahead of print on 14 May 2007.
These authors contributed equally to this work.
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |